A Phase II, Multicentre Trial Evaluating the Efficacy of De-Escalated Bisphosphonate Therapy in Metastatic Breast Cancer Patients at Low-Risk of Skeletal-Related Events

Breast Cancer Research and Treatment - Netherlands
doi 10.1007/s10549-014-2906-x

Related search